Ubiquitination and Proteolysis in Acute Lung Injury

被引:32
|
作者
Vadasz, Istvan [1 ]
Weiss, Curtis H. [2 ]
Sznajder, Jacob I. [2 ]
机构
[1] Univ Giessen, Dept Internal Med, Lung Ctr, D-35392 Giessen, Germany
[2] Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA
基金
美国国家卫生研究院;
关键词
RESPIRATORY-DISTRESS-SYNDROME; ALVEOLAR FLUID CLEARANCE; PLASMA PROTEASOME LEVEL; K-ATPASE; CIRCULATING PROTEASOMES; 26S PROTEASOME; NA; K-ATPASE ENDOCYTOSIS; MECHANICAL VENTILATION; INFLAMMATORY RESPONSE; MEDIATED DEGRADATION;
D O I
10.1378/chest.11-1660
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Ubiquitination is a posttranslational modification that regulates a variety of cellular functions depending on timing, subcellular localization, and type of tagging, as well as modulators of ubiquitin binding leading to proteasomal or lysosomal degradation or nonproteolytic modifications. Ubiquitination plays an important role in the pathogenesis of acute lung injury (ALI) and other lung diseases with pathologies secondary to inflammation, mechanical ventilation, and decreased physical mobility. Particularly, ubiquitination has been shown to affect alveolar epithelial barrier function and alveolar edema clearance by targeting the Na,K-ATPase and epithelial Na+ channels upon lung injury. Notably, the proteasomal system also exhibits distinct functions in the extracellular space, which may contribute to the pathogenesis of ALI and other pulmonary diseases. Better understanding of these mechanisms may ultimately lead to novel therapeutic modalities by targeting elements of the ubiquitination pathway. CHEST 2012; 141(3):763-771
引用
收藏
页码:763 / 771
页数:9
相关论文
共 50 条
  • [11] Ventilatory Strategies in Acute Lung Injury
    Calderini, Edoardo
    Sher, Sara
    Allegritti, Eleonora
    ANAESTHESIA, PHARMACOLOGY, INTENSIVE CARE AND EMERGENCY MEDICINE, A P I C E 2010, 2011, : 77 - 88
  • [12] Emerging drugs for acute lung injury
    Impellizzeri, Daniela
    Bruschetta, Giuseppe
    Esposito, Emanuela
    Cuzzocrea, Salvatore
    EXPERT OPINION ON EMERGING DRUGS, 2015, 20 (01) : 75 - 89
  • [13] Cardiopulmonary interactions in acute lung injury
    Schmidt, Gregory A.
    CURRENT OPINION IN CRITICAL CARE, 2013, 19 (01) : 51 - 56
  • [14] Biomarkers in Acute Lung Injury: Insights into the Pathogenesis of Acute Lung Injury
    Cross, L. J. Mark
    Matthay, Michael A.
    CRITICAL CARE CLINICS, 2011, 27 (02) : 355 - +
  • [15] Acute lung injury
    Parekh, Dhruv
    Dancer, Rachel C.
    Thickett, David R.
    CLINICAL MEDICINE, 2011, 11 (06) : 615 - 618
  • [16] Tabersonine attenuates lipopolysaccharide-induced acute lung injury via suppressing TRAF6 ubiquitination
    Zhang, Depeng
    Li, Xiaozong
    Hu, Yudong
    Jiang, Hongchao
    Wu, Yaxian
    Ding, Yunhe
    Yu, Kaikai
    He, Huiqiong
    Xu, Jingsong
    Sun, Lei
    Qian, Feng
    BIOCHEMICAL PHARMACOLOGY, 2018, 154 : 183 - 192
  • [17] Acute lung injury in critical neurological illness
    Hoesch, Robert E.
    Lin, Eric
    Young, Mark
    Gottesman, Rebecca F.
    Altaweel, Laith
    Nyquist, Paul A.
    Stevens, Robert D.
    CRITICAL CARE MEDICINE, 2012, 40 (02) : 587 - 593
  • [18] Incidence and Outcomes of Pediatric Acute Lung Injury
    Zimmerman, Jerry J.
    Akhtar, Saadia R.
    Caldwell, Ellen
    Rubenfeld, Gordon D.
    PEDIATRICS, 2009, 124 (01) : 87 - 95
  • [19] Corticosteroids in Acute Lung Injury: The Dilemma Continues
    Mokra, Daniela
    Mikolka, Pavol
    Kosutova, Petra
    Mokry, Juraj
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (19)
  • [20] Pathophysiology of acute lung injury in patients with acute brain injury: the triple-hit hypothesis
    Ziaka, Mairi
    Exadaktylos, Aristomenis
    CRITICAL CARE, 2024, 28 (01)